News Press ReleasesSep 20, 2024 AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine – ELAHERE® AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) byKyriakos Papadopoulos7 minute read
